Clinical trial
Bergen Psychosis Project 2 - The Bergen-Stavanger-Innsbruck-Trondheim Study
NCT01446328 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bergen Psychosis Project 2 - The Bergen-Stavanger-Innsbruck-Trondheim Study
- Lead sponsor
- Haukeland University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- December 31, 2017
- Enrollment
- 151 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.